FDA Accelerates Biosimilar Approvals to Cut Treatment Costs for Chronic Diseases
The U.S. Food and Drug Administration (FDA) has announced measures to streamline the development of biosimilar drugs. These steps aim […]
MoblO2 Device Trial Announced to Address Oxygenation in Chronic Respiratory Conditions
A recent announcement sheds light on a new clinical trial intended to evaluate the MoblO2 medical device for maintaining oxygenation
Unapproved Medical Device Trial Raises Questions for Compliance Teams
A clinical trial is underway involving a medical device that has not yet received U.S. FDA approval or clearance. This
Regulatory Advances in NIRS Monitoring for Neonatal AKI Management
NYU Langone Health is presently recruiting patients for a groundbreaking investigation into the application of Near-Infrared Spectroscopy (NIRS) monitoring in
Innovative Device Offers Non-Invasive Solution for Intracranial Pressure Estimation
Clinical trial updates: A new approach to estimating intracranial pressure (ICP) has been introduced through ongoing studies. The CPMX3 device,
Lantheus Holdings, Inc. Stock Performance and Corporate Profile Update
Lantheus Holdings, Inc. (NASDAQ: LNTH) has seen a recent variation in its stock price, drawing attention from market watchers. This
Zingerman’s Recall: Allergy Hazard Due to Undeclared Peanuts & Cashews
Zingerman’s Candy Manufactory, based in Ann Arbor, Michigan, has issued an urgent recall concerning two of its candy bar products,
FDA Notice: E.A. Sween Issues Recall for Deli Express BBQ Pulled Pork Sandwich Due to Choking Risk
E.A. Sween Company has initiated a recall of its Deli Express® BBQ Pulled Pork sandwiches after discovering the potential presence
FDA Alert: Purity Products Recalls ‘MyBladder’ Supplement Over Potential E. coli Contamination
On October 27, 2025, Purity Products, based in Plainview, NY, issued a voluntary recall of one lot of its dietary
Evaluating Tixel and P-TIOX Combination for Treating Periocular Wrinkles: Latest Clinical Insights
Recent updates from an ongoing clinical trial reveal promising insights into a combination approach using Tixel technology and a peptide-based